Filing Details
- Accession Number:
- 0001209191-14-045555
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-02 19:40:46
- Reporting Period:
- 2014-07-01
- Filing Date:
- 2014-07-02
- Accepted Time:
- 2014-07-02 19:40:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1438133 | Tandem Diabetes Care Inc | TNDM | Surgical & Medical Instruments & Apparatus (3841) | 204327508 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1365369 | F John Sheridan | C/O Tandem Diabetes Care, Inc., 11045 Roselle Street San Diego CA 92121 | Evp & Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-07-01 | 2,000 | $1.11 | 3,198 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-07-01 | 2,000 | $16.42 | 1,198 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2014-07-01 | 2,000 | $0.00 | 2,000 | $1.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 175,040 | 2014-02-25 | 2023-04-23 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2014, in multiple transactions at prices ranging from $16.35 to $16.50. The reporting person undertakes to provide the SEC, the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
Billionaire Hedge Funds
